4//SEC Filing
Regado Biosciences Inc 4
Accession 0001140361-14-000627
CIK 0001311596operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 5:17 PM ET
Size
16.6 KB
Accession
0001140361-14-000627
Insider Transaction Report
Form 4
Zelenkofske Steven
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2014-01-01+75,000→ 75,000 totalExercise: $4.77Exp: 2023-12-31→ Common Stock, par value $0.001 per share (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest as to 25% of the shares underlying the option on the one-year anniversary of the date of grant and as to the remaining 75% of the shares underlying the option in equal monthly installments over the subsequent 36 months on the last day of each month.
Documents
Issuer
Regado Biosciences Inc
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 5:17 PM ET
- Size
- 16.6 KB